Renata Mikołajczak Selected Research

Renata Mikołajczak Research Topics

Disease

15	Neoplasms (Cancer) 11/2022 - 01/2005
8	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 07/2006
6	Neoplasm Metastasis (Metastasis) 03/2021 - 10/2003
6	Solitary Pulmonary Nodule 09/2006 - 01/2004
5	Prostatic Neoplasms (Prostate Cancer) 05/2021 - 10/2003
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021 - 01/2005
3	Insulinoma 01/2016 - 04/2013
2	Lymphoma (Lymphomas) 10/2020 - 01/2008
2	Infections 01/2017 - 01/2004
2	Inflammation (Inflammations) 01/2017 - 01/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2015 - 01/2008
1	medullary Thyroid cancer 11/2021
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Primary Myelofibrosis (Myelosclerosis) 05/2021
1	Nesidioblastosis (Nesidioblastosis of Pancreas) 01/2016
1	Hypoglycemia (Reactive Hypoglycemia) 01/2016
1	Munchausen Syndrome (Munchhausen Syndrome) 01/2016
1	Liver Neoplasms (Liver Cancer) 08/2014
1	Disease Progression 08/2014
1	Heart Diseases (Heart Disease) 04/2012
1	Glioma (Gliomas) 01/2004
1	Cicatrix (Scar) 01/2004
1	Carcinoid Tumor (Carcinoid) 10/2003
1	Leiomyosarcoma 10/2003
1	Melanoma (Melanoma, Malignant) 10/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2003

Drug/Important Bio-Agent (IBA)

12	EDDA (NiEDDA)IBA 01/2016 - 01/2004
10	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 07/2004
7	Radioisotopes (Radionuclides)IBA 10/2021 - 01/2006
6	RadiopharmaceuticalsIBA 11/2021 - 01/2004
6	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2021 - 01/2005
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 11/2022 - 08/2009
4	LigandsIBA 03/2021 - 10/2007
3	Cholecystokinin B ReceptorIBA 01/2021 - 10/2007
3	Peptide Receptors (Peptide Receptor)IBA 01/2020 - 10/2007
3	Exenatide (Byetta)FDA Link 01/2016 - 04/2013
2	BombesinIBA 01/2021 - 08/2009
2	minigastrinIBA 01/2017 - 03/2016
2	Technetium (Technetium 99m)IBA 01/2017 - 01/2004
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016 - 04/2013
2	GastrinsIBA 01/2016 - 10/2007
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2016 - 01/2006
2	Chromogranin AIBA 01/2016 - 10/2007
2	Peptides (Polypeptides)IBA 08/2009 - 10/2007
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2007 - 09/2006
2	technetium Tc 99m hydrazinonicotinyl-Tyr(3)-octreotideIBA 09/2006 - 07/2006
1	aniline (aniline hydrobromide)IBA 10/2021
1	diglycolic acidIBA 10/2021
1	Bombesin Receptors (Bombesin Receptor)IBA 10/2021
1	EnzymesIBA 05/2021
1	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 01/2021
1	DOTA-NHSIBA 10/2020
1	Chelating AgentsIBA 10/2020
1	177Lu-DOTA-rituximabIBA 10/2020
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 04/2018
1	exametazime FDA Link 01/2017
1	Cholecystokinin (Pancreozymin)IBA 03/2016
1	Insulin (Novolin)FDA Link 01/2016
1	C-PeptideIBA 01/2016
1	Glucagon (Glukagon)FDA Link 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	indoleacetic acid (indole acetic acid)IBA 01/2016
1	Rituximab (Mabthera)FDA Link 01/2015
1	Serum AlbuminIBA 08/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2013
1	Gastrin-Releasing PeptideIBA 08/2009
1	Glu-OctagastrinIBA 10/2007
1	3-Tyr-octreotideIBA 10/2007
1	99mTc-octreotideIBA 01/2006
1	TurpentineIBA 01/2004
1	Tyrosine (L-Tyrosine)FDA Link 01/2004
1	hippuryl-glycyl-glycine (HIGG)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2003

Therapy/Procedure

12	Therapeutics 10/2021 - 01/2004
4	Precision Medicine 11/2022 - 04/2018
4	Radiotherapy 01/2017 - 01/2004
1	Castration 05/2021
1	Radioimmunotherapy 10/2020
1	Molecular Targeted Therapy 06/2017
1	Palliative Care (Palliative Therapy) 08/2014
1	Microspheres (Microsphere) 08/2014
1	Neoadjuvant Therapy 01/2012
1	Aftercare (After-Treatment) 01/2008
1	Injections 01/2004